Fitch Downgrades McKesson's L-T Rating to 'BBB+'; Outlook Negative

07-02-2014 Business Wire HealthComments (0)

BiotechnologyMcKessonPharmaceuticalUSA

Fitch Ratings has downgraded the long-term ratings of McKesson Corp. (NYSE: MCK), including the long-term Issuer Default Rating (IDR), to 'BBB+' from 'A-'. The Rating Outlook is Negative. A full list of rating actions follows at the end of this release. The rating actions follow the close of MCK's agreements with Franz Haniel & Cie GmbH (Haniel) and Elliott Fund Management (Elliott) to acquire the firms' respective stock and convertible bond holdings of Celesio AG

Read more on Business Wire Health

Your Comments

Login to add a comment

There are no comments yet. Be the first and leave a response!

Back to top